Phibro Animal Health Corporation Announces Chief Financial Officer Changes

Rhea-AI Summary

Phibro Animal Health Corporation (PAHC) announced the appointment of Glenn C. David as Chief Financial Officer, effective February 9, 2024. Mr. David brings over 30 years of experience in commercial and financial leadership roles, with his most recent role being Executive Vice President and Group President, US Operations, Diagnostics, Biodevices, and Insurance at Zoetis Inc. Phibro's Chairman, President, and CEO, Jack Bendheim, expressed excitement about David's appointment, highlighting his wealth of knowledge and experience in the animal health industry.

TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024. Mr. Richard Johnson, who is currently serving as Phibro’s interim Chief Financial Officer since September 29, 2023, will continue with Phibro for a period of time in an advisory capacity to ensure a smooth transition with his successor.

Mr. David brings over 30 years of experience in commercial and financial leadership roles. Mr. David’s most recent role was Executive Vice President and Group President, US Operations, Diagnostics, Biodevices and Insurance at Zoetis Inc. Prior to that, he served as Executive Vice President and Group President, International Operations, Aquaculture, Biodevices and Insurance at Zoetis. Mr. David was the Chief Financial Officer at Zoetis from 2016-2021, where he maintained a well-capitalized and financially disciplined business, creating significant value for shareholders and earlier in his career, he served as Senior Vice President of Finance Operations for Zoetis during its Initial Public Offering in 2013. Before the Zoetis IPO, Mr. David served in various financial roles at Pfizer Inc., including Vice President of Global Finance for Pfizer Animal Health and Vice President of Finance for the U.S. Primary Care franchise.

“I am very excited to welcome Glenn to Phibro. Glenn brings a wealth of knowledge and experience not only in financial matters but in the animal health industry which will be beneficial for Phibro as we continue to grow our business and bring value to our shareholders. He brings the skills and experience needed to play a key role in Phibro’s future success,” said Jack Bendheim, Phibro’s Chairman, President, and Chief Executive Officer. “I also want to thank Dick Johnson, who previously served as Phibro’s Chief Financial Officer for more than 18 years, for leading us through this transition period and for his help in ensuring the continued success of our business.”

Mr. David has a Bachelor of Science in Finance from Binghamton University and a Masters of Business Administration in Finance from New York University.

About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240206595634/en/

Phibro Animal Health Corporation

Richard Johnson

Chief Financial Officer, Phibro Animal Health Corporation

+1-201-329-7300

Or

investor.relations@pahc.com

Source: Phibro Animal Health Corporation

FAQ

Who is the new Chief Financial Officer of Phibro Animal Health Corporation?

The new Chief Financial Officer of Phibro Animal Health Corporation is Glenn C. David.

When will Glenn C. David assume the role of Chief Financial Officer?

Glenn C. David will assume the role of Chief Financial Officer effective February 9, 2024.

What is the ticker symbol for Phibro Animal Health Corporation?

The ticker symbol for Phibro Animal Health Corporation is PAHC.

What is Glenn C. David's most recent role before joining Phibro?

Glenn C. David's most recent role was Executive Vice President and Group President, US Operations, Diagnostics, Biodevices, and Insurance at Zoetis Inc.

What are Glenn C. David's qualifications?

Glenn C. David has a Bachelor of Science in Finance from Binghamton University and a Masters of Business Administration in Finance from New York University.